medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2007, Number 1

<< Back Next >>

Ann Hepatol 2007; 6 (1)

Association of HFE mutations (C282Y and H63D) with iron overload in blood donors from Mexico City

Baptista-González HA, Rosenfeld-Mann F, Trueba-Gómez R, Bermejo-Martínez L, Méndez-Sánchez N

Language: English
References: 29
Page: 55-60
PDF size: 87.44 Kb.


Text Extraction

Background and objective: Iron overload has been associated with HFE mutations (C282Y and H63D). We investigated the association between these mutations and high serum ferritin in a sample of healthy adult men. Design and methods: We enrolled unrelated blood donors from three hospitals in Mexico City in a cross-sectional study. Serum ferritin (SF) was determined to define iron overload, and HFE gene mutations were identified by PCR–RFLP. Results: We evaluated 2524 male blood donors and included 246 individuals for each group. We identified 108 individuals with HFE gene mutation, 20.5 % were heterozygote (wt/H63D or wt/C282Y) and the remaining homozygote (H63D/H63D). The genotype wt/C282Y was observed in two cases, none cases with C282Y/C282Y. The allelic frequency of H63D and C282Y was 0.115 and 0.002, respectively. We observed different association for H63D allele with iron overload (OR 1.54, CI 95 %1.16-2.03) and none in allele C282Y. Although values averages were different, the extreme dispersion of serum ferritin not showed statistically significant differences between H63D and C282Y alleles and ferritin concentrations. Conclusions: The male unrelated blood donors from Mexico City with iron overload prevalence of 13.8% hold similarities with other populations from Europe o America continent, respecting the allele frequency H63D. Nevertheless, allele frequency C282Y is lower than that observed in descendents from northern Europe. We have not observed statistic difference of SF or iron overload frequency by effect of both alleles.


REFERENCES

  1. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95: 1472–7.

  2. Andrews CN. Molecular control of iron metabolism. Best Pract Res Clin Haematol 2005; 18: 159–69.

  3. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005; 18: 171–82.

  4. Waalen J, Nordestgaard GB, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 2005; 18: 203–20.

  5. DuBois S, Kowdley KV. Review article: targeted screening for hereditary haemochromatosis in high-risk groups. Aliment Pharmacol Ther 2004; 20: 1–14.

  6. Ruiz AG. Analysis of HFE codon 63/282 (H63D/C282Y) gene variants in Mexican mestizos, blood donors and patients with hereditary haemochromatosis. Arch Med Res 2000; 31: 422–4.

  7. Hunt JR, Zeng H. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 2004; 80: 924–31.

  8. Rossi E, Bulsara MK, Olynk JK, Cullen DJ, Summerville L, Powell LW. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 2001; 47: 202–8.

  9. Yen AW, Fancher TL, Bowlus CL. Revisiting hereditary hemochromatosis: current concepts and progress. Am J Med 2006; 119: 391–9.

  10. Baptista GH, Rosenfeld MF, Trueba GR, Méndez SN, Uribe EM. Evaluation of iron overload in healthy adult residents of Mexico City. Arch Med Res 2005; 36: 142–7.

  11. Norma Oficial Mexicana para la disposición de sangre humana con fines terapéuticos. NOM SSA003. Diario Oficial de la Federación, 1993.

  12. Koziol JA, Ho NJ, Felitti VJ, Beutler E. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 2001; 47: 1804–10.

  13. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005; 352: 1769–78.

  14. Rochette J, Pointon JJ, Fisher CA, Perera G, Arambepola M, Arichchi DS, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999; 64: 1056–62.

  15. Hanson EH, Imperatore G, Burke E. HFE gene and hereditary Hemochromatosis: A HuGe review. Am J Epidemiol 2001; 154: 193-206.

  16. Hoppe C, Watson RM, Long CM, Lorey F, Robles L, Klitz W, et al. Prevalence of HFE mutations in California newborns. Pediatr Hematol Oncol 2006; 23: 507-16.

  17. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001; 114: 474–84.

  18. Schmitt B, Golub RM, Green R. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. An Intern Med 2006; 143: 522-536.

  19. De Gobbi M, D’Antico S. Castagno S, Testa D, Merlini R, Bondo A, Camaschella C. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. Haematologica 2004; 89: 1161-67.

  20. Sanchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R. Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatol 2003; 38: 745-50.

  21. Alvarez S, Mesa MS, Bandres F, Arroyo E. C282Y and H63D mutation frequencies in a population from central Spain. Dis Markers 2001; 17(2): 111-4.

  22. Steinberg KK, Cogswell ME, Chang CJ, Caudill PS, McQuillan MG, Bowman AB, et al. Prevalence of C282 and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001; 285: 2216–22.

  23. Dias NKV, Meirelles de souza AF, Fonseca CJM, Proietti FA, Portes MRS, Leite de Souza J. Hereditary Hemochromatosis. Population screening based on phenotype in Brazilian blood donors. J Clin Gastroenterol 2005; 39: 430-34.

  24. Vizzi E, Loureriro CL, Geder M, de las Nieves GCM, Rodriguez LA, Gerace L, et al. Mutation analysis of the HFE gene associated with Hereditary Hemochromatosis in a Venezuelan sample. Ann Hematol 2005; 84: 802-6.

  25. Wohllk N, Zapata R, Acuna M, Reyes H, Navarro A, Roa I, Roa JC. HFE gene mutations in Chile. Ann Intern Med 2003; 139: 708-9.

  26. Fragoso JM, Juarez-Cedillo T, Hernandez-Pacheco G, Ramirez E, Zuniga J, Izaguirre R, de la Pena A, Granados J, Vargas-Alarcon G. Cytochrome P4501A1 polymorphisms in the Amerindian and Mestizo populations of Mexico. Cell Biochem Funct 2005; 23: 189-93.

  27. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003; 31: 262–7.

  28. Milman N, Byg KE, Ovesen L, Kirchhoff M, Jurgensen KS. Iron status in Danish men 1984–94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 2002; 68: 332–40.

  29. Scotet V, Merour MC, Mercier AY, Chanu B, Le Faou T, Raguenes O, et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 2003; 158: 129–34.




2020     |     www.medigraphic.com